Notice of AGM

the offices of Travers Smith LLP, 3 Stonecutter Street, London EC4A 4AW, England at 3.00 pm (BST). The Company has published the formal notice of the meeting (the “Notice”) on its website which can be accessed

using the following LINK. Proxy voting forms are being posted to all shareholders providing details of how to access the Notice and instructions for voting. A copy of the Notice together

with proxy voting forms is being posted to all shareholders who are required to receive or have formally requested to receive these documents.

The Notice contains a letter from the Chairman of the Company, Mr Michael Lynch-Bell, which is set out below

in Appendix 1.

The person who arranged for the release of this announcement on behalf of the Company was Andrew Khov,

Vice President, Investor Relations and Business Development.

See www.serabigold.com for more information and follow us on X @Serabi_Gold

Appendix 1

To the holders (“Shareholders”) of ordinary shares of £0.10 each in the capital of the Company (the “Ordinary Shares”), and, for information only, to the holders of Options and other share related securities.

Dear Shareholder

This document provides the formal notice (the “Notice”) of the 2026 Annual General Meeting of the Company to be held at the offices of Travers Smith LLP, 3 Stonecutter Street, London EC4A 4AW, England on 18 June 2026 at 3.00 p.m. (London time) (the “AGM”). The purpose of the AGM is to seek Shareholders’ approval of the resolutions.

Action to be taken by Shareholders

A form of proxy for use by Shareholders accompanies this document. To be valid, forms of proxy must be completed and returned so as to be received at either the offices of the Company’s UK Registrar, Computershare Investor Services Plc, The Pavilions, Bridgwater Road, Bristol, BS99 6ZZ or the offices of the Company’s Canadian Registrar, Computershare Investor Services Inc., 320 Bay Street, 14th Floor, Toronto, Ontario M5H 4A6 by not later than 3.00 p.m. (London time) (10.00 a.m. Eastern time) on 16 June 2026. Alternatively, Shareholders can appoint a proxy electronically by going to either www.investorcentre.co.uk/eproxy (for UK appointments) or www.investorvote.com (for Canadian appointments) or, if they hold their shares in CREST, Shareholders can appoint a proxy using the CREST electronic proxy appointment service, in each case by not later than 3.00 p.m. (London time) (10.00 a.m. Eastern time) on 16 June 2026 in accordance with the instructions set out in the “Proxy Instructions” section below and the form of proxy.

Completion and return of a form of proxy will not prevent Shareholders from attending and voting in person at the AGM should they so wish.

Beneficial Shareholders (as defined in the “Voting by Beneficial Shareholders” section below on page 09) should note that only registered Shareholders or their duly authorised proxy holders are entitled to vote at the AGM. Each Beneficial Shareholder should ensure that their voting instructions are communicated to the appropriate person well in advance of the AGM

Background

As I noted in our Annual Report, 2025 was a standout year in the long-term growth strategy of the Company. The momentum in our growth has continued through 2026, as the Company remains on track for executing its growth strategy. In 2025, we delivered on a number of key milestones that I believe position the Company for further value-accretive growth, underpinning long-term returns for our shareholders and reinforcing our resilience amidst market volatility.

The matters being considered at the 2026 Annual General Meeting, as set out in the Notice, are items that are routinely considered at such meetings.

I am very much looking forward to meeting with Shareholders at the AGM and having the opportunity to discuss with them my hopes and expectations for Serabi for the future.

Canadian Designated Foreign Issuer Status

The Company is a “designated foreign issuer” for the purposes of Canadian Securities Administrators’ National Instrument 71-102 - Continuous Disclosure and Other Exemptions Relating to Foreign Issuer (“NI 71-102”) and, as such, the Company is not subject to the same ongoing reporting requirements as most other reporting issuers in Canada. Generally, the Company complies with Canadian ongoing reporting requirements by complying with the regulatory requirements of AIM, which is a “foreign regulatory authority” (as defined in NI 71-102), and filing any documents required to be filed with or furnished to AIM with the securities regulatory authorities in Canada.

Recommendation and importance of vote

The Directors consider that the resolutions set out in the Notice being put to the AGM are in the best interests of the Company and its Shareholders and are most likely to promote the success of the Company for the benefit of the Shareholders as a whole.

Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the proposed resolutions as they intend to do so in respect of their own holdings, where relevant, amounting to an aggregate of 505,796 Ordinary Shares, representing approximately 0.67% of the Company’s Ordinary Shares in issue at the date of this document.

Yours faithfully

(Signed) "Michael D Lynch-Bell"

Michael D Lynch-Bell

Non-executive Chairman

Assay Results

Assay results reported within this release are those provided by the Company's own onsite laboratory facilities at Palito and have not yet been independently verified. Serabi closely monitors the performance of its own facility against results from independent laboratory analysis for quality control purpose. As a matter of normal practice, the Company sends duplicate samples derived from a variety of the Company's activities to accredited laboratory facilities for independent verification. Since mid-2019, over 10,000 exploration drill core samples have been assayed at both the Palito laboratory and certified external laboratory, in most cases the ALS laboratory in Belo Horizonte, Brazil. When comparing significant assays with grades exceeding 1 g/t gold, comparison between Palito versus external results record an average over-estimation by the Palito laboratory of 6.7% over this period. Based on the results of this work, the Company's management are satisfied that the Company's own facility shows sufficiently good correlation with independent laboratory facilities for exploration drill samples. The Company would expect that in the preparation of any future independent Reserve/Resource statement undertaken in compliance with a recognised standard, the independent authors of such a statement would not use Palito assay results without sufficient duplicates from an appropriately certificated laboratory.

Notice